API Product   :    Letrozole*
CEP   :    -
WCC   :    ?
Therapeutic Use    :    Cytostatic Hormone Therapy; Antineoplastics
Originator   :    Novartis
CAS No.    :    112809-51-5
Trade Name.   :    FEMARA
Molecular Weight   :    285.303 g/mol
Molecular Formula   :    C17H11N5
This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen.
Letrozole, sold under the brand name Femara among others, is an aromatase inhibitor which is used in the treatment of hormonally-responsive breast cancer after surgery.